Stay updated with breaking news from Forefront Analytics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Chardan Capital restated their buy rating on shares of Achilles Therapeutics (NASDAQ:ACHL – Free Report) in a research note published on Monday morning, Benzinga reports. They currently have a $11.00 target price on the stock. Chardan Capital also issued estimates for Achilles Therapeutics’ FY2024 earnings at ($1.58) EPS. Achilles Therapeutics Trading Up 2.0 % NASDAQ […]
Seven Springs Wealth Group LLC grew its stake in iShares Floating Rate Bond ETF (BATS:FLOT – Free Report) by 2.6% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 169,146 shares of the company’s stock after acquiring an additional 4,356 shares during the period. iShares Floating Rate […]
Laurel Wealth Advisors LLC trimmed its position in iShares Floating Rate Bond ETF (BATS:FLOT – Free Report) by 31.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,514 shares of the company’s stock after selling 2,563 shares during the quarter. Laurel Wealth Advisors […]
Kanawha Capital Management LLC decreased its position in iShares Floating Rate Bond ETF (BATS:FLOT – Free Report) by 11.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 34,626 shares of the company’s stock after selling 4,625 shares during the quarter. Kanawha Capital […]
Live Oak Private Wealth LLC lessened its holdings in iShares Floating Rate Bond ETF (BATS:FLOT – Free Report) by 93.4% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,020 shares of the company’s stock after selling 56,466 shares during the period. Live Oak Private Wealth LLC’s […]